CrystalGenomics, Inc.
17 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NCT05841472) | CrystalGenomics, Inc. | 2023-08-23 |
| Pharmacokinetics and Safety of 'CG-745 IV' and 'CG-750' in Healthy Male Adults (NCT05345912) | CrystalGenomics, Inc. | 2019-12-16 |
| Drug-Drug Interaction Study of "CG-651" in Healthy Volunteer (NCT05370716) | CrystalGenomics, Inc. | 2019-11-11 |
| CG-549 Tablet Pharmacokinetics Study (NCT05393856) | CrystalGenomics, Inc. | 2019-09-23 |
| Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers (NCT03774355) | CrystalGenomics, Inc. | 2018-12-17 |
| Drug-Drug Interaction Study of "CG100650" in Healthy Volunteers (NCT03775629) | CrystalGenomics, Inc. | 2018-12-01 |
Track CrystalGenomics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.